Comments
Loading...

iShares Biotechnology ETF

IBBNASDAQ
Logo brought to you by Benzinga Data
Sector
Healthcare
Region
US
AUM
7.70B
Fund Score

iShares Biotechnology ETF (NASDAQ:IBB) Quotes, Forecast and News Summary

iShares Biotechnology ETF (NASDAQ: IBB) stock price, news, charts, stock research, profile.

Open$139.53
High$141.10
52 Wk High$150.57
AUM7.70B
Dividend-
Ex-Div Date-
Volume1.67M
Market Cap$53.44B
Mgmt Fee0.45%
P/E Ratio23.37
Prev. Close$137.96
Low$139.37
52 Wk Low$117.28
Shares Out55.10M
Yield-
Div. Freq-
Avg. Volume Daily1.44M
Beta0.74
Avg. Expense Ratio0.45%
P/B Ratio-

FAQ

Q

How do I buy iShares Biotechnology ETF (IBB) stock?

A

You can purchase shares of iShares Biotechnology ETF (NASDAQ:IBB) through any online brokerage.

View our list of the best stock brokerages

Q

Who are iShares Biotechnology ETF (IBB) competitors?

A

There are no as such competitors for iShares Biotechnology ETF.

Q

What is the forecast, or price target, for iShares Biotechnology ETF (IBB) stock?

A

There is no analysis for iShares Biotechnology ETF to provide a consensus price target.

Q

What is the current price for iShares Biotechnology ETF (IBB)?

A

The stock price for iShares Biotechnology ETF (NASDAQ: IBB) is $139 last updated November 25, 2024 at 6:21 AM EST.

Q

Does iShares Biotechnology ETF (IBB) pay a dividend?

A

A quarterly cash dividend of 0.20 per share of Class A Common Stock. The quarterly cash dividend was payable on September 30, 2024 to stockholders of record on September 25, 2024.

Q

When is iShares Biotechnology ETF (NASDAQ:IBB) reporting earnings?

A

iShares Biotechnology ETF does not have any upcoming earnings scheduled.

Q

Is iShares Biotechnology ETF (IBB) going to split?

A

There is no upcoming split for iShares Biotechnology ETF.

Open$139.53
High$141.10
52 Wk High$150.57
AUM7.70B
Dividend-
Ex-Div Date-
Volume1.67M
Market Cap$53.44B
Mgmt Fee0.45%
P/E Ratio23.37
Prev. Close$137.96
Low$139.37
52 Wk Low$117.28
Shares Out55.10M
Yield-
Div. Freq-
Avg. Volume Daily1.44M
Beta0.74
Avg. Expense Ratio0.45%
P/B Ratio-
ETF Details
SectorHealthcare
CategoryHigh Performer-Mid Growth
Investment StyleMid Cap Growth
Fund InceptionFeb 5, 2001
Managers
Paul Whitehead
Jennifer Hsui
Greg Savage
DefinitionThis Equity Fund Portfolio contains majority of stocks with strong financial performance and average growth potential
Investment Policy
To pursue its objective, the Fund seeks to track the investment results of the NYSE Biotechnology Index (the Underlying Index), which measures the performance of U.S.-listed securities of companies that are classified according to the ICE Uniform Sector Classification schema within the Biotechnology Sub-Industry Group (as determined by ICE Data Indices, LLC or its affiliates (collectively Index Provider or IDI)) and that also meet other eligibility criteria determined by the Index Provider, including minimum market capitalization and liquidity requirements. Companies classified within the Biotechnology Sub-Industry Group include those companies that are engaged in the research and development of therapeutic treatments but that are not focused on the commercialization and mass production of pharmaceutical drugs..
Top ETF Holdings
SymbolNameShare %
GILDGilead Sciences Inc8.57%
REGNRegeneron7.98%
VRTXNvaesrtex Pharmaceutic...7.89%
AMGNAmgen Inc.7.87%
IQVI Q V I A Holdings Inc...4.07%
MRNAModerna therapeutics3.75%
MTDMettler-Toledo Interna...2.99%
BIIBBiogen Inc. Com2.88%
ALNYAlnylam Pharmace2.79%
ASArgenx Se Ads2.43%